Volume 15, Issue 1 (1-2017)                   IJRM 2017, 15(1): 49-54 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Pourali L, Ayati S, Tavakolizadeh S, Soleimani H, Teimouri Sani F. Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A prospective randomized trial. IJRM 2017; 15 (1) :49-54
URL: http://ijrm.ir/article-1-789-en.html
Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A prospective randomized trial
Leila Pourali1 , Sedigheh Ayati * 2, Shirin Tavakolizadeh3 , Hourieh Soleimani3 , Fatemeh Teimouri Sani3
1- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. , ayatis@mums.ac.ir
3- Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:   (3260 Views)
Background: Clomiphene citrate is one of the effective drugs for infertilitytreatment due to oligo-ovulation or anovulation. Intrauterine insemination (IUI) isone of more adherent methods for treatment of infertile cases which is followed bycontrolled ovarian hyperstimulation (COH).
Objective: the aim of this study was to evaluate Clomiphene citrate versus letrozolewith gonadotropins in IUI cycles.
Materials and Methods: In this prospective randomized trial, 180 infertile patientswho were referred to Milad Hospital were selected. The first group received 5mg/day letrozole on day 3-7 of menstrual cycle. The second group received 100mg/day Clomiphene in the same way as letrozole. In both groups, humanmenopausal gonadotropin was administered every day starting on day between 6-8of cycle. Ovulation was triggered with urinary Human Chorionic Gonadotropin(5000 IU) when have two follicles of ≥16 mm. IUI was performed 36 hr later.
Results: The number of matured follicles, cycle cancellation, and abortion were thesame in both groups. Endometrial thickness was higher at the time of humanmenopausal gonadotropin administration in letrozole group. Chemical and clinicalpregnancy rates were much higher in letrozole group. Ovarian hyperstimulation wassignificantly higher in clomiphene group.
Conclusion: Letrozole appears to be a good alternative to clomiphene citrate withfewer side effects.
Keywords: Ovarian stimulation, Gonadotropin, Letrozole, Clomiphene citrate.
Full-Text [PDF 141 kb]   (886 Downloads) |   |   Full-Text (HTML)  (358 Views)  
Type of Study: Original Article |
References
1. Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, et al. A randomized clinical trial of Clomiphenee citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod 2007; 22: 792-797. [DOI:10.1093/humrep/del441]
2. Safarinejad MR. Infertility among couples in a population‐based study in Iran: prevalence and associated risk factors. Int J Androl 2008; 31: 303-314. [DOI:10.1111/j.1365-2605.2007.00764.x]
3. Tomlinson MJ, Amissah-Arthur JB, Thompson KA, Kasraie JL, Bentick B. Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Hum Reprod 1996; 11: 1892-1896. [DOI:10.1093/oxfordjournals.humrep.a019513]
4. Barroso G1, Menocal G, Felix H, Rojas-Ruiz JC, Arslan M, Oehninger S. Comparison of the efficacy of the aromatase inhibitor letrozole and Clomiphenee citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial. Fertil Steril 2006; 86: 1428-1431. [DOI:10.1016/j.fertnstert.2006.03.044]
5. Greenblatt RB, Barfield WE, Jungck EC, Ray AW. Induction of ovulation with mrl/41: Preliminary report. JAMA 1961; 178:101-104. [DOI:10.1001/jama.1961.03040410001001]
6. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of Clomiphenee citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002; 78: 280-285. [DOI:10.1016/S0015-0282(02)03241-7]
7. Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H. Effects of Clomiphenee citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 1997; 67: 256- 260. [DOI:10.1016/S0015-0282(97)81907-3]
8. Nelson LM1, Hershlag A, Kurl RS, Hall JL, Stillman RJ. Clomiphenee citrate directly impairs endometrial receptivity in the mouse. Fertil Steril 1990; 53: 727-731.
9. Ibrahim MI1, Moustafa RA, Abdel-Azeem AA. Letrozole versus Clomiphenee citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial. Arch Gynecol Obstet 2012; 286: 1581-1587. [DOI:10.1007/s00404-012-2478-0]
10. Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, et al. Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med 2015; 373: 1230-1240. [DOI:10.1056/NEJMoa1414827]
11. Liu A, Zheng C, Lang J, Chen W. Letrozole versus Clomiphenee citrate for unexplained infertility: A systematic review and meta-analysis. J Obstet Gynaecol Res 2014; 40: 1205-1216. [DOI:10.1111/jog.12393]
12. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192: 381-386. [DOI:10.1016/j.ajog.2004.08.013]
13. Shahrokh Tehrani Nejad E, Abediasl Z, Rashidi BH, Azimi Nekoo E, Shariat M, Amirchaghmaghi E. Comparison of the efficacy of the aromatase inhibitor letrozole and Clomiphene citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. J Assist Reprod Genet 2008; 25: 187-190. [DOI:10.1007/s10815-008-9209-2]
14. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th Ed. WHO publication, Switzerland, 2010; 271.
15. Ibrahim MI, Moustafa RA, Abdel-Azeem AA. Letrozole versus Clomiphenee citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial. Arch Gynecol Obstet 2012; 286: 1581-1587. [DOI:10.1007/s00404-012-2478-0]
16. Akbari S, Ayazi Roozbahani M, Ayazi Roozbahani F. Comparing of letrozole versus Clomiphenee citrate combined with gonadotropins in intrauterine insemination cycles. Iran J Reprod Med 2012; 10: 29-32.
17. Badawy A, Elnashar A, Totongy M. Clomiphenee citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial. Fertil Steril 2009; 92: 1355-1359. [DOI:10.1016/j.fertnstert.2008.06.013]
18. Angel M, Ghose S, Gowda M. A randomized trial comparing the ovulation induction efficacy of Clomiphenee citrate and letrozole. J Nat Sci Biol Med 2014; 5: 450-452. [DOI:10.4103/0976-9668.136241]
19. Zadehmodares S, Niyakan M, Sharafy SA, Yazdi MH, Jahed F. Comparison of treatment outcomes of infertile women by Clomiphenee citrate and letrozole with gonadotropins underwent intrauterine insemination. Acta Med Iran 2012; 50: 18-20.
20. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, et al. Letrozole versus Clomiphenee for infertility in the polycystic ovary syndrome. N Engl J Med 2014; 371: 119-129. [DOI:10.1056/NEJMoa1313517]
21. Poheung C. Use of letrozole versus Clomiphenee citrate for superovulation in patients undergoing intrauterine insemination: a systematic review. [MSc Thesis]. China. The University of Hong Kong (Pokfulam, Hong Kong); 2014.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb